TY - JOUR T1 - Venous thromboembolism in COVID-19 JF - Saudi Medical Journal JO - Saudi Med J SP - 979 LP - 990 DO - 10.15537/smj.2022.43.9.20220316 VL - 43 IS - 9 AU - Naif Saad ALGhasab AU - Leen A. Altamimi AU - Mohammed Salem Alharbi AU - Sulaman S. ALMesned AU - Aditya K. Khetan Y1 - 2022/09/01 UR - http://smj.org.sa/content/43/9/979.abstract N2 - Objectives: To summarize cases of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT) among coronavirus disease (COVID-19) patients and discuss their symptoms, diagnostic method, clinical features, and prognosis.Methods: All major databases were searched for relevant studies published between December 1, 2019 and May 5, 2021.Results: A total of 233 articles were identified, 22 describing 48 patients were included. A total of 79.1% had PE and 20.9% had DVT. Most patients were men, with a mean age of 56 years. Comorbidities were present in 70.8%, and 85.4% had at least one risk factor of VTE. 56.3% had received anticoagulation therapy. Most patients were treated in the general ward. Complications occurred in 27.1% of the patients, and recovery was achieved in 80.4%.Conclusion: Venous thromboembolism must be suspected even in patients who had received prior anticoagulant regimens or in stable cases, especially in males, the elderly, and patients with comorbidities and high D-dimer levels. ER -